Published in Qual Health Care on December 01, 1998
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29
How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England. Int J Equity Health (2007) 1.11
Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England. Ther Clin Risk Manag (2005) 0.78
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet (1994) 9.13
Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet (1996) 7.73
A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24
Meta-analysis: principles and procedures. BMJ (1997) 6.87
Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ (1993) 6.23
Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med (1995) 4.29
An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med (1995) 4.08
Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ (1997) 3.51
Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA (1992) 3.37
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull (1994) 3.09
Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ (1998) 3.07
A systematic review of the effectiveness of promoting lifestyle change in general practice. Fam Pract (1997) 3.04
Lipid-lowering for prevention of coronary heart disease: what policy now? Clin Sci (Lond) (1996) 2.88
Stopping smoking after myocardial infarction. Lancet (1974) 2.87
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ (1997) 2.44
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S) Circulation (1997) 2.34
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1996) 2.31
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Does cholesterol screening result in negative labeling effects? Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project. Arch Intern Med (1991) 2.14
Modelling the effects of increased physical activity on coronary heart disease in England and Wales. J Epidemiol Community Health (1997) 2.08
Oat products and lipid lowering. A meta-analysis. JAMA (1992) 1.90
Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med (1997) 1.85
Identification and treatment of risk factors for coronary heart disease in general practice: a possible screening model. Br Med J (Clin Res Ed) (1988) 1.85
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med (1997) 1.79
Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis (1984) 1.75
Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ (1995) 1.75
Psychologic effects of the diagnosis and treatment of hypercholesterolemia: lessons from case studies. Am J Med (1991) 1.65
Effectiveness and hazards of case finding for a high cholesterol concentration. BMJ (1990) 1.60
Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med (1994) 1.56
Comparison of the use of four desktop analysers in six urban general practices. Br J Gen Pract (1992) 1.47
A pilot scheme for improving the accuracy of serum cholesterol measurement in Scotland and Northern Ireland. Ann Clin Biochem (1993) 1.44
The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol (1990) 1.26
Motivational effect of cholesterol measurement in general practice health checks. Br J Gen Pract (1992) 1.22
Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. Am J Public Health (1997) 1.16
Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond (1997) 1.07
Near patient testing in general practice: attitudes of general practitioners and practice nurses, and quality assurance procedures carried out. Br J Gen Pract (1994) 1.06
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation (1995) 1.03
Drug therapy for coronary heart disease: the Sheffield table. Lancet (1998) 0.99
Total error assessment of five methods for cholesterol screening. Clin Chem (1993) 0.99
Science and advertising. Circulation (1982) 0.97
Is knowing your cholesterol number harmful? J Clin Epidemiol (1994) 0.93
Lowering risk without lowering cholesterol: implications for national cholesterol policy. Ann Intern Med (1996) 0.92
Reduced cholesterol is associated with recent minor illness: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (1997) 0.90
Serum total cholesterol and risk of hospitalization, and death from respiratory disease. Int J Epidemiol (1997) 0.90
Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. J Nutr (1997) 0.89
Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration. J Epidemiol Community Health (1994) 0.86
Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. Hypertension (1997) 0.81
Comparison of the use of a dry chemistry analyser in primary care in Norway and the United Kingdom. Br J Gen Pract (1993) 0.78
The 'diet heart' hypothesis in secondary prevention of coronary heart disease. Eur Heart J (1997) 0.78
Whole-blood test for total cholesterol by a self-metering, self-timing disposable device with built-in quality control. Clin Chem (1997) 0.77
Home cholesterol testing. Lancet (1993) 0.76
Eight compact analysis systems evaluated for measuring total cholesterol. Clin Chem (1994) 0.76
Comparing two strategies to modify dietary behavior and serum cholesterol. J Cardiovasc Risk (1997) 0.76
Exercise versus heart attack: questioning the consensus? Res Q Exerc Sport (1996) 0.76
Cholesterol screening and cholesterol lowering treatment. Qual Health Care (1993) 0.76
Health inequalities among British civil servants: the Whitehall II study. Lancet (1991) 24.79
Misleading meta-analysis. BMJ (1995) 11.94
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Why are the Japanese living longer? BMJ (1990) 8.54
Meta-Analysis. Potentials and promise. BMJ (1997) 8.06
Income inequality and mortality: importance to health of individual income, psychosocial environment, or material conditions. BMJ (2000) 8.02
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ (1993) 7.14
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13
Meta-analysis: principles and procedures. BMJ (1997) 6.87
Deprivation in infancy or in adult life: which is more important for mortality risk? Lancet (1991) 6.84
Electron microscopical reconstruction of the anterior sensory anatomy of the nematode Caenorhabditis elegans.?2UU. J Comp Neurol (1975) 6.58
Bias in location and selection of studies. BMJ (1998) 6.47
Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ (1993) 6.23
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Second thoughts on the Jarman index. BMJ (1991) 5.99
A global profile of germline gene expression in C. elegans. Mol Cell (2000) 5.97
Who benefits from medical interventions? BMJ (1994) 5.58
Social class differences in years of potential life lost: size, trends, and principal causes. BMJ (1990) 5.06
Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ (1997) 4.98
Association of cardiovascular disease risk factors with socioeconomic position during childhood and during adulthood. BMJ (1996) 4.88
Chemotaxis by the nematode Caenorhabditis elegans: identification of attractants and analysis of the response by use of mutants. Proc Natl Acad Sci U S A (1973) 4.76
Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ (1994) 4.67
Increasing inequalities in the health of the nation. BMJ (1994) 4.66
Routinely administered questionnaires for depression and anxiety: systematic review. BMJ (2001) 4.54
Income inequality, the psychosocial environment, and health: comparisons of wealthy nations. Lancet (2001) 4.48
Please bypass the PORT. BMJ (1994) 4.37
Population requirement for primary hip-replacement surgery: a cross-sectional study. Lancet (1999) 4.29
Social capital--is it a good investment strategy for public health? J Epidemiol Community Health (2000) 4.25
Deprivation and mortality in Glasgow: changes from 1980 to 1992. BMJ (1994) 4.17
Allocating resources to health authorities: results and policy implications of small area analysis of use of inpatient services. BMJ (1994) 4.17
The independent inquiry into inequalities in health is welcome, but its recommendations are too cautious and vague. BMJ (1998) 3.97
Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88
Fertilization and sperm competition in the nematode Caenorhabditis elegans. Dev Biol (1979) 3.78
Are we really dying for a tan? BMJ (1999) 3.74
Magnesium and myocardial infarction. Lancet (1994) 3.74
An investigation into the effectiveness of an early intervention method for delayed language development in young children. Int J Lang Commun Disord (2000) 3.68
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Weighting in the dark: resource allocation in the new NHS. BMJ (1993) 3.60
Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut (2004) 3.55
Earliest Homo. Nature (1992) 3.52
Height, leg length, and cancer risk: a systematic review. Epidemiol Rev (2001) 3.52
Modelling in economic evaluation: an unavoidable fact of life. Health Econ (1997) 3.40
How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol (1991) 3.37
Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet (1996) 3.37
Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29
Milk, coronary heart disease and mortality. J Epidemiol Community Health (2001) 3.23
Mortality variations as a measure of general practitioner performance: implications of the Shipman case. BMJ (2000) 3.20
Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ (1996) 3.18
When does cardiovascular risk start? Past and present socioeconomic circumstances and risk factors in adulthood. J Epidemiol Community Health (1999) 3.15
Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ (1998) 3.12
Volume and outcome in coronary artery bypass graft surgery: true association or artefact? BMJ (1995) 3.12
Cost effectiveness of antenatal screening for cystic fibrosis. BMJ (1995) 3.05
Postal urine specimens: are they a feasible method for genital chlamydial infection screening? Br J Gen Pract (1999) 3.02
Cardiorespiratory disease in men and women in urban Scotland: baseline characteristics of the Renfrew/Paisley (midspan) study population. Scott Med J (1995) 2.99
Evidence-informed patient choice. Practical issues of involving patients in decisions about health care technologies. Int J Technol Assess Health Care (1998) 2.95
Health effects of anticipation of job change and non-employment: longitudinal data from the Whitehall II study. BMJ (1995) 2.92
Lay epidemiology and the rationality of responses to health education. Br J Gen Pract (1991) 2.88
Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol (2001) 2.85
Adult height and mortality in London: early life, socioeconomic confounding, or shrinkage? J Epidemiol Community Health (1995) 2.71
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart (1999) 2.69
Characterization of temperature-sensitive, fertilization-defective mutants of the nematode caenorhabditis elegans. Genetics (1978) 2.68
Screening and case finding instruments for depression. Cochrane Database Syst Rev (2005) 2.67
Consensus conferences as drug promotion. Lancet (1993) 2.65
A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess (2007) 2.62
Intersex, a temperature-sensitive mutant of the nematode Caenorhabditis elegans. Dev Biol (1978) 2.62
A systematic review of compression treatment for venous leg ulcers. BMJ (1997) 2.61
An uncertain future: the health effects of threats to employment security in white-collar men and women. Am J Public Health (1998) 2.57
Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol (2001) 2.56
Income inequality and mortality: why are they related? BMJ (1996) 2.55
Income and health: what is the nature of the relationship? Soc Sci Med (1999) 2.51
Increasing the accessibility of data. BMJ (1994) 2.51
The ghost of Christmas past: health effects of poverty in London in 1896 and 1991. BMJ (2001) 2.49
Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med (1995) 2.48
Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci (2002) 2.43
Life course exposure and later disease: a follow-up study based on medical examinations carried out in Glasgow University (1948-68). Public Health (1999) 2.39
Shared care in diabetes. BMJ (1995) 2.39
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med (2001) 2.35
Larger sperm outcompete smaller sperm in the nematode Caenorhabditis elegans. Proc Biol Sci (1998) 2.35
Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect Immun (1990) 2.32
The limits of lifestyle: re-assessing 'fatalism' in the popular culture of illness prevention. Soc Sci Med (1992) 2.23
Sperm morphogenesis in wild-type and fertilization-defective mutants of Caenorhabditis elegans. J Cell Biol (1981) 2.18
Magnitude and causes of mortality differences between married and unmarried men. J Epidemiol Community Health (1993) 2.17
Evaluation of an inspiratory muscle trainer in healthy humans. Respir Med (2001) 2.16
Informed choice for users of health services: views on ultrasonography leaflets of women in early pregnancy, midwives, and ultrasonographers. BMJ (1996) 2.16
The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest (1998) 2.15
Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Trans R Soc Trop Med Hyg (1993) 2.15
Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring. BMJ (2000) 2.13
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain (2000) 2.11
Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet (2000) 2.10
The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord (1997) 2.10
Vesicle fusion, pseudopod extension and amoeboid motility are induced in nematode spermatids by the ionophore monensin. Cell (1980) 2.09
Awareness and determinants of family planning practice in Jimma, Ethiopia. Int Nurs Rev (2006) 2.08
The design of prospective epidemiological studies: more subjects or better measurements? J Clin Epidemiol (1993) 2.08
People, places and coronary heart disease risk factors: a multilevel analysis of the Scottish Heart Health Study archive. Soc Sci Med (1997) 2.06
Fitness to practise: Unbelievably arrogant. Br Dent J (2014) 2.03